Stock Events

Stock Events

Lisata Therapeutics 

$1.6500
21
+$0.01+0.61% Friday 20:00
-$0.03-1.82%Friday 23:02After hours

Statistics

Day High
1.66
Day Low
1.66
52W High
5.07
52W Low
0.99
Volume
500
Avg. Volume
-
Mkt Cap
14.87M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q2 2026
Next
-0.76
-0.67
-0.58
-0.49
Expected EPS
N/A
Actual EPS
N/A

Financials

-9,756.47%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
170,000Revenue
-16.59MNet Income

Analyst Ratings

0.00Average Price Target
The highest estimate is 0.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LSTA. It's not an investment recommendation.
Apple
4
AAPL
Amazon
4
AMZN
Johnson & Johnson
4
JNJ
Rocket Lab
4
RKLB

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biomarin Pharmaceutical
BMRN
Mkt Cap12.52B
BioMarin Pharmaceutical develops and commercializes innovative therapies for rare genetic diseases, overlapping with Lisata's focus on novel treatments.
Alnylam Pharmaceuticals
ALNY
Mkt Cap31.73B
Alnylam Pharmaceuticals focuses on RNAi therapeutics for genetically defined diseases, competing in the genetic disorder treatment space.
Sarepta Therapeutics
SRPT
Mkt Cap2.2B
Sarepta Therapeutics is involved in the discovery and development of RNA-based therapeutics, targeting conditions similar to those Lisata aims at.
Vertex Pharmaceuticals
VRTX
Mkt Cap137.3B
Vertex Pharmaceuticals concentrates on creating new treatments for cystic fibrosis and other serious diseases, potentially competing in therapeutic areas.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals is known for its innovative biologics, directly competing in the biopharmaceutical space for rare diseases.
Biogen
BIIB
Mkt Cap32.28B
Biogen focuses on neurology, rare diseases, and autoimmune conditions, areas that might overlap with Lisata's therapeutic targets.
AMGEN
AMGN
Mkt Cap233.78B
Amgen is a biotech giant with a broad portfolio that includes treatments for serious illnesses, possibly competing in some areas.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences has a diverse range of products, including for rare diseases, which could place it in competition with Lisata.
Novo Nordisk
NVO
Mkt Cap201.64B
Novo Nordisk specializes in diabetes care and other serious chronic conditions, potentially competing in the broader healthcare market.
Pfizer
PFE
Mkt Cap159.36B
Pfizer has a wide-ranging portfolio that includes treatments for rare diseases and other serious conditions, making it a competitor in various therapeutic areas.

About

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
Show more...
CEO
David J. Mazzo
Employees
21
Country
United States
ISIN
US1280583022
WKN
000A3DWGC

Listings

LSE
GB
0HS8.LSE
STU
DE
8NE.STU
MU
DE
8NE.MU
BOATS
BOATS
LSTA.BOATS

0 Comments

Share your thoughts

FAQ

What is Lisata Therapeutics stock price today?▼
The current price of LSTA is $1.65 USD — it has increased by +0.61% in the past 24 hours. Watch Lisata Therapeutics stock price performance more closely on the chart.
What is Lisata Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Lisata Therapeutics stocks are traded under the ticker LSTA.
Is Lisata Therapeutics stock price growing?▼
LSTA stock has fallen by -2.37% compared to the previous week, the month change is a +47.32% rise, over the last year Lisata Therapeutics has showed a -23.96% decrease.
What is Lisata Therapeutics market cap?▼
Today Lisata Therapeutics has the market capitalization of 14.87M
When is the next Lisata Therapeutics earnings date?▼
Lisata Therapeutics is going to release the next earnings report on November 05, 2026.
What is Lisata Therapeutics revenue for the last year?▼
Lisata Therapeutics revenue for the last year amounts to 170,000 USD.
What is Lisata Therapeutics net income for the last year?▼
LSTA net income for the last year is -16.59M USD.
How many employees does Lisata Therapeutics have?▼
As of September 05, 2026, the company has 21 employees.
In which sector is Lisata Therapeutics located?▼
Lisata Therapeutics operates in the Health & Wellness sector.
When did Lisata Therapeutics complete a stock split?▼
The last stock split for Lisata Therapeutics was on September 15, 2022 with a ratio of 1:15.
Where is Lisata Therapeutics headquartered?▼
Lisata Therapeutics is headquartered in BASKING RIDGE, United States.